Category: Pediatrics
Keywords: Passenger Safety (PubMed Search)
Posted: 11/18/2011 by Mimi Lu, MD
Click here to contact Mimi Lu, MD
Child Passenger Safety.
Perhaps one of the greatest contributions emergency physicians can provide to society comes in the form of anticipatory guidance. It is important to take the opportunity during the ED encounter to provide information to parents to prevent future injuries. Child passenger safety is one clear example. With over 330,000 pediatric visits to EDs across the US annually attributed to motor vehicle collisions, the need to provide clear recommendations to parents on how to restrain their children in their vehicle is paramount. Despite a recent survey of over 1000 EPs in which 85% of respondents indicated child passenger safety should routinely be a part of pediatric MVC discharge instructions, only 36% of EPs knew the latest guidelines on child passenger safety. The American Academy of Pediatrics provides such guidelines. These recommendations were recently adjusted in 2011.
(1) Infants up to 2 years must be in REAR-facing car seats
(2) Children through 4 years in forward-facing car safety seats
(3) Belt-positioning booster seat for children through at least 8 years old
(4) Lap-and-shoulder seat belts for those who have outgrown booster seats. How does one know when the child has outgrown the booster seat?
a. Can the child sit with his/her knees bent at the edge of the seat?
b. Does the shoulder belt lie across the middle of the chest/shoulder?
c. Does the lap belt lie across the upper thighs and not the abdomen?
(5) Children younger than 13 should sit in the rear seats
Special Thanks to JV Nable, MD, EMT-P for writing this pearl.
1. Zonfrillo MR, Nelson KA, Durbin DR. Emergency physician's knowledge and provision of child passenger safety information. Acad Emerg Med 2011;18:145-151.
2. Durbin DR. Child passenger safety. Pediatrics 2011;127:788-793
Category: Toxicology
Keywords: Toxic, epidermal, necrolysis (PubMed Search)
Posted: 11/17/2011 by Fermin Barrueto
Click here to contact Fermin Barrueto
TEN is a rare, life-threatening dermatologic emergency characterized initially by erythema and tenderness. It is followed by a severe exfoliation that resembles a severe burn patient. Classically occurs within days of the exposure of the drug. Nikolsky's sign may be present - not pathognomonic.
The following is a short list of medications that can cause this lethal reaction:
allopurinol, bactrim, nitrofurantoin, NSAIDs, penicillin, phenytoin, lamotrigine, sulfasalazine
Treatment: transfer to a burn center may be needed, steroids are not generally recommended however immunomodulators are beginning to show promise - IVIG, cyclosporine and cyclophosphamide
See pic that is attached for example of the sloughing
Category: Neurology
Keywords: Myasthenia Graves, MG, edrophonium, Tensilon (PubMed Search)
Posted: 11/16/2011 by Aisha Liferidge, MD
Click here to contact Aisha Liferidge, MD
Category: Critical Care
Posted: 11/15/2011 by Mike Winters, MBA, MD
(Updated: 11/27/2024)
Click here to contact Mike Winters, MBA, MD
Hypertensive Emergency Pearls
Marik PE, Rivera R. Hypertensive emergencies: an update. Curr Opin Crit Care 2011; 17:569-80.
Category: Geriatrics
Keywords: acute MI, MI, myocardial infarction, acute coronary syndrome, elderly, geriatric (PubMed Search)
Posted: 11/13/2011 by Amal Mattu, MD
Click here to contact Amal Mattu, MD
The 30-day mortality for patients < 65 years of age who are diagnosed with and treated for acute MI is 3%. In contrast, the 30-day mortality for patients > 85 years of age who are diagnosed with and treated for acute MI is 30%! Obviously the mortality is far higher if the patient's diagnosis is delayed or missed; or if the patient is not treated appropriately.
This simple statistic highlights the critical importance of being aggressive with diagnostic and therapeutic planning for elder patients with potential ACS. We cannot afford to be cavalier in their evaluation or treatment.
Category: Orthopedics
Keywords: wrist arthrocentesis radiocarpal joint (PubMed Search)
Posted: 11/12/2011 by Brian Corwell, MD
(Updated: 11/27/2024)
Click here to contact Brian Corwell, MD
Arthrocentesis of the Wrist
First locate and feel comfortable identifying two important landmarks:
1) Lister's tubercle is an elevation found in the center of the dorsal aspect of the distal end of the radius
http://www.aafp.org/afp/2004/0415/afp20040415p1941-f2.jpg
2) The extensor pollicis longus (EPL) tendon runs in a grove just radially to Lister's tubercle. Active extension of wrist and thumb aid with identification.
http://www.rad.washington.edu/academics/academic-sections/msk/muscle-atlas/upper-body/extensor-pollicis-longus/atlasImage
A) Positioning: Place wrist in ulnar deviation and 20 - 30 degrees of flexion. Apply longitudinal traction to the fingers of the hand.
B) Technique: Insert a small needle (22g) just distal to the tubercle and on the ulnar side of the EPL tendon.
http://img.medscape.com/pi/emed/ckb/clinical_procedures/79926-79928-80032-1477044tn.jpg
http://www.youtube.com/watch?v=nlPdb_mymw4&feature=related
http://www.youtube.com/watch?v=UVG7fZvZD-s&feature=related
Roberts and Hedges Clinical Procedures in Emergency Medicine
Category: Pediatrics
Posted: 11/11/2011 by Rose Chasm, MD
(Updated: 11/27/2024)
Click here to contact Rose Chasm, MD
MedStudy Pediatrics Board Review
Core Curriculum
Category: Toxicology
Keywords: idiopathic intracranial hypertension, pseudotumor cerebri, tetracycline, vitamin a (PubMed Search)
Posted: 10/11/2011 by Bryan Hayes, PharmD
(Updated: 11/10/2011)
Click here to contact Bryan Hayes, PharmD
Several medications have been linked to causing idiopathic intracranial hypertension (pseudotumor cerebri). Be sure to record an accurate medication history in patients you suspect of having this diagnosis.
Withdrawal of the offending agent will generally resolve the symptoms.
Category: Neurology
Keywords: lithium toxicity, hemodialysis, whole bowel irrigation (PubMed Search)
Posted: 11/9/2011 by Aisha Liferidge, MD
(Updated: 11/27/2024)
Click here to contact Aisha Liferidge, MD
Perrone J, Chatterjee P. "Lithium Poisoning." UpToDate. May 2011. Retrieved from: http://www.uptodate.com/contents/lithium-poisoning?source=search_result&search=lithium+tocity&selectedTitle=2%7E150#H24.
Category: Critical Care
Keywords: tamponade, critical care, intubation, positive pressure, PEA arrest (PubMed Search)
Posted: 11/8/2011 by Haney Mallemat, MD
Click here to contact Haney Mallemat, MD
Positive-pressure ventilation (e.g., mechanical ventilation) increases intrathoracic pressure potentially reducing venous return, right-ventricular filling, and cardiac output.
Pericardial tamponade similarly causes hemodynamic compromise through increased pericardial pressure which reduces right-ventricular filling and cardiac output.
When mechanically ventilating a patient with known or suspected pericardial tamponade the mechanisms above may be additive, causing cardiovascular collapse and possibly PEA arrest.
For the patient with known or suspected pericardial tamponade consider draining the pericardial effusion prior to intubation or delaying intubation until absolutely necessary.
If intubation is unavoidable, consider maintaining the intrathoracic pressure as low as possible (by keeping the PEEP and tidal volumes to a minimum) to ensure adequate cardiac filling and cardiac output.
Ho, A. et. al. Timing of tracheal intubation in traumatic cardiac tamponade: A word of caution. Resuscitation, 80(2), 272–274.
Follow me on Twitter (@criticalcarenow) or Google+ (+haney mallemat)
Category: Cardiology
Keywords: obesity, shock, blood pressure (PubMed Search)
Posted: 11/6/2011 by Amal Mattu, MD
(Updated: 11/27/2024)
Click here to contact Amal Mattu, MD
Blood pressure cuffs tend to OVERESTIMATE true blood pressure in obese patients. Even larger cuffs tend to do this as well. While low blood pressures are often reliable in diagnosing shock, be wary of assuming a "normal" blood pressure (e.g. SBP 100-120s) rules out shock in an obese patient who is sick. A-lines might be necessary to accurately assess the blood pressure.
[adapted from ACEP talk by Dr. Tiffany Osborn]
Category: Pharmacology & Therapeutics
Keywords: nicardipine, labetalol, blood pressure (PubMed Search)
Posted: 10/30/2011 by Bryan Hayes, PharmD
(Updated: 11/5/2011)
Click here to contact Bryan Hayes, PharmD
A recent randomized trial compared nicardipine as a continuous infusion to labetalol boluses to determine which one was more effective at lowering blood pressure to a target range within 30 minutes.
Median initial SBP for the 226 patients was 212 mm Hg. Within 30 minutes, nicardipine patients more often reached target range than labetalol (91.7 vs. 82.5%, P = 0.039). Of 6 BP measures (taken every 5 minutes) during the study period, nicardipine patients had higher rates of five and six instances within target range than labetalol (47.3% vs. 32.8%, P = 0.026).
What this means: Nicardipine is a reasonable choice for patients needing acute lowering of blood pressure (e.g., ischemic stroke with tPa). Nicardipine seems to achieve faster and smoother lowering of blood pressure than labetalol therapy with less blood pressure readings outside the target range.
Peacock WF, Varon J, Baumann BM, et al. CLUE: a randomized comparative effectiveness trial of IV nicardipine versus labetalol use in the emergency department. Crit Care 2011;15(3):R157. Epub 2011 Jun 27.
Category: Toxicology
Keywords: salicylate, aspirin, alkalosis, acidosis (PubMed Search)
Posted: 11/3/2011 by Ellen Lemkin, MD, PharmD
(Updated: 11/27/2024)
Click here to contact Ellen Lemkin, MD, PharmD
Salicylates:
Overall, this results in a mixed respiratory alkalosis and metabolic acidosis.
Micromedex; Poisindex, salicylate poisoning.
Category: Neurology
Keywords: stroke, iPhone, NIH Stroke Scale (PubMed Search)
Posted: 11/2/2011 by Aisha Liferidge, MD
(Updated: 11/27/2024)
Click here to contact Aisha Liferidge, MD
Category: Critical Care
Posted: 11/1/2011 by Mike Winters, MBA, MD
(Updated: 11/27/2024)
Click here to contact Mike Winters, MBA, MD
Mechanical Ventilation in Patients with Pulmonary HTN
Category: Visual Diagnosis
Posted: 10/30/2011 by Haney Mallemat, MD
(Updated: 10/31/2011)
Click here to contact Haney Mallemat, MD
72 year-old man, one-week post right fem-pop bypass presents with painful blue and black toe. Diagnosis?
Answer: Blue-Toe Syndrome
Hirschman, J. et al. Blue (or purple) toe syndrome. J Am Acad Dermatol.2009 Jan;60(1):1-20
O'Keeffe S, et al. Blue toe syndrome: Causes and management.Arch Intern Med. 1992 Nov;152(11):2197-202.
Follow me on Twitter (@criticalcarenow) or Google+ (+haney mallemat)
Category: Cardiology
Keywords: defibrillation, tachydysrhythmia, ventricular fibrillation (PubMed Search)
Posted: 10/30/2011 by Amal Mattu, MD
Click here to contact Amal Mattu, MD
Today's cardiology pearl provided by EMS guru Dr. Ben Lawner. Consider this one if you are caring for a patient with what appears to be shock-resistant VFib.
An intervention that has its roots in the electrophysiology lab has now gained traction on the front lines of resuscitation: double sequential defibrillation. Prospective studies are currently underway to examine the feasibility of this technique. New Orleans (LA) EMS boasts several anectodal accounts of survival, with neurologically intact recovery, from refractory ventricular fibrillation. The next time you can’t stop the fibbing, consider this:
· Apply TWO sets of defibrillator pads to the patient; one in traditional sternum/apex configuration and the other in anterior/posterior configuration
· If ventricular fibrillation persists despite several shocks, coordinate the simultaneous firing of BOTH defibrillators
Some caveats:
This treatment is based upon EP lab data; each MONOPHASIC defibrillator was set at 360J. EMS services in New Orleans and Wake County (NC) have used two biphasic defibrillators, each set a 200J. There is not sufficient data to make any widespread recommendation, but the idea of double sequential defibrillation may be another tool in a limited ACLS bag of tricks for patients who simply cannot come out of V-fib. New Orleans EMS has initiated the double-defib protocol after four shocks, and Wake County’s protocol recommends initiation after five. Wake's protocol also recommends firing the defirbillators "as synchronously as possible."
DH Hoch, WP Batsford, SM Greenberg, CM McPherson, et al. Double sequential defibrillation for refractory ventricular defibrillation. J. Am Cardiol. 1994;23:1141-45.
Category: Toxicology
Keywords: overdose, methotrexate (PubMed Search)
Posted: 10/27/2011 by Fermin Barrueto
(Updated: 11/27/2024)
Click here to contact Fermin Barrueto
Methotrexate is a chemotherapeutic that is utilized in non-Hodgkin lymphoma and breast CA. It is also used as an immunosuppressant for rheumatoid arthritis and psoriasis. Finally, we see it used in the ED for the treatment of ectopic pregnancy. Overdose, often unintentional, can have a lethal outcome.
Toxicity: LFTs rise, N/V, stomatitis, mucositis, leukopenia, thrombocytopenia, renal failure
Antidote: Leukovorin (Folinic Acid)
Other Tx: Carboxypeptidase G2, Charcoal Hemoperfusion, HD (possible)
Category: Neurology
Keywords: myasthenia graves, MG (PubMed Search)
Posted: 10/26/2011 by Aisha Liferidge, MD
(Updated: 11/27/2024)
Click here to contact Aisha Liferidge, MD
- Mask-like face
- Eyelid weakness
-- leads to ptosis
-- exacerbated by sustained upward gaze
-- improved by closing the eyes for a short while
- Extraocular motion abnormality
-- usually affects more than one extraocular muscle
-- may be assymetrical
-- may result in mild proptosis
- Weak palatal muscles
-- nasal-sounding voice
-- nasal regurgitation of food
- Weak jaw muscles
- Absent gag reflex
- Pupils normal
Category: Critical Care
Keywords: xigris, activated protein C, sepsis, multi-organ failure, resuscitation (PubMed Search)
Posted: 10/25/2011 by Haney Mallemat, MD
Click here to contact Haney Mallemat, MD
On October 25, 2011, Eli Lilly announced a voluntary-recall of activated drotrecogin alfa (Xigris) following a recent trial (PROWESS-SHOCK), which demonstrated no survival benefit when using the drug when compared to placebo.
Activated drotrecogin alfa is a recombinant form of human activated protein C previously recommended for adults with severe sepsis and a high-risk of death (APACHE II > 25 or multi-organ failure); it is included in the 2008 International Sepsis Guidelines (Grade 2b recommendation).
The PROWESS-SHOCK trial reported an all-cause mortality rate of 26.4% in the drotrecogin alfa group compared with 24.2% in the placebo group; this difference was not statistically significant.
Interestingly, the study also found that severe bleeding (the drug's main side-effect) was found to be 1.2% in the activated drotrecogin alfa group compared to 1.0% for the placebo group (also non-significant) suggesting it does not increase the risk of bleeding as it had previously been reported.
Hospitals should revise their sepsis guidelines based on this recent news.
www.medscape.com/viewarticle/752169?sssdmh=dm1.728719&src=nl_newsalert
Dellinger, R. P., et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Critical Care Medicine, 36(1), 296–327. doi:10.1097/01.CCM.0000298158.12101.41
Follow me on Twitter (@criticalcarenow) or Google+ (+haney mallemat)